Imago BioSciences - Ownership and Business Overview

Life ScienceCompany

Imago BioSciences Ownership

Who owns Imago BioSciences?

Imago BioSciences is owned by Merck. It was acquired on November 21, 2022.

Was Imago BioSciences formerly PE-backed?

Yes. Imago BioSciences was formerly owned by 1 private investor.

Imago BioSciences Business Overview

Where is Imago BioSciences headquartered?

Imago BioSciences is headquartered in South San Francisco, California.

How many employees does Imago BioSciences have?

Imago BioSciences has 27 employees.

What sector is Imago BioSciences in?

Imago BioSciences is a life science company.

When was Imago BioSciences founded?

Imago BioSciences was founded in 2012.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 293 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 256 by strategics.

Imago BioSciences

Imago BioSciences, Inc.

329 Oyster Point Blvd. 3rd Floor,
South San Francisco, California 94080
United States,
(415) 529-5055
www.imagobio.com

Imago BioSciences is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. Imago BioSciences was formed in 2012 and is based in South San Francisco, California.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.